Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FEGTF
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,363
Award facts
- Contract value 100% obligated
- $4,362.58 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $4,362.58 by the Defense Logistics Agency on January 22, 2026. This firm fixed-price delivery order, with an ultimate completion date of January 23, 2026, represents a continuation of the company's supply of pharmaceutical products and medical consumables to support Department of Defense healthcare operations. The award carries no set-aside designation, reflecting DMS Pharmaceutical Group's competitive capability in unrestricted federal procurement.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which was awarded in November 2025 with a $499.999 billion ceiling value and completion date of December 31, 2036. As a regional prime vendor contractor within the broader $30.3 billion PPV-G GEN V acquisition strategy, DMS Pharmaceutical Group supplies a comprehensive range of pharmaceuticals including branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical consumables to military healthcare facilities worldwide. The company's product portfolio encompasses treatments across multiple therapeutic categories, from oncology and immunosuppressant agents to emergency medications and routine pharmaceuticals, supporting the recurring medical supply needs of the federal military medical system globally.
Quick answers
Who was awarded contract SPE2DU26FEGTF?
SPE2DU26FEGTF was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DU26FEGTF worth?
The government has obligated $4,363 on SPE2DU26FEGTF.
Is contract SPE2DU26FEGTF an order under another contract?
Yes. SPE2DU26FEGTF is a delivery order under SPE2DU25D9524, an indefinite delivery contract.
Was contract SPE2DU26FEGTF competed?
The extent of competition for SPE2DU26FEGTF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award